MAPK1 and cancer: The canonical Ras-ERK MAPK signalling pathway is frequently deregulated in human cancers with activating mutations found in upstream components of the pathway including receptor tyrosine kinases (RTKs), Ras GTPases, the MAPK kinase kinase Braf and MAPK kinase (MEK) [121].